A case of takotsubo cardiomyopathy precipitated by lumiracoxib, a selective COX-2 inhibitor
| dc.contributor.author | Ker, James A. | |
| dc.contributor.author | Van Wyk, C.J. | |
| dc.date.accessioned | 2008-03-15T07:24:15Z | |
| dc.date.available | 2008-03-15T07:24:15Z | |
| dc.date.issued | 2007-11 | |
| dc.description.abstract | Considerable controversy exists regarding the cardiovascular safety of COX-2 inhibitors, both in patients with and without established cardiovascular disease. Currently, the major focus is on thrombotic complications presenting as myocardial infarction. In this report, we present a case of takotsubo cardiomyopathy, also known as the apical ballooning syndrome, precipitated by the use of lumiracoxib. We are concerned that this might be the first case of COX-2 inhibitor-induced apical ballooning syndrome and that more may follow. | en |
| dc.format.extent | 244840 bytes | |
| dc.format.mimetype | application/pdf | |
| dc.identifier.citation | Ker, J & Van Wyk, CJ 2007, 'A case of takotsubo cardiomyopathy precipitated by lumiracoxib, a selective COX-2 inhibitor', Cardiovascular Journal of Africa, vol. 18, no. 6, pp. 383-384. [http://www.cvjsa.co.za] | en |
| dc.identifier.issn | 1015-9657 | |
| dc.identifier.uri | http://hdl.handle.net/2263/4733 | |
| dc.language.iso | en | en |
| dc.publisher | Clinics Cardiv | en |
| dc.rights | Clinics Cardiv | en |
| dc.subject | Cardiovascular disease | en |
| dc.subject | COX-2 | en |
| dc.subject | Takotsubo cardiomyopathy | en |
| dc.subject | Apical ballooning syndrome | en |
| dc.subject.lcsh | Cardiovascular system -- Diseases | |
| dc.subject.lcsh | Cyclooxygenase 2 -- Inhibitors | |
| dc.subject.mesh | Takotsubo Cardiomyopathy | |
| dc.title | A case of takotsubo cardiomyopathy precipitated by lumiracoxib, a selective COX-2 inhibitor | en |
| dc.type | Article | en |